Direxion Daily S&P Biotech Bull 3X Shares
LABU
LABU
17 hedge funds and large institutions have $48.3M invested in Direxion Daily S&P Biotech Bull 3X Shares in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less call options, than puts
Call options by funds: $41.2M | Put options by funds: $42.9M
6% less funds holding
Funds holding: 18 → 17 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
17
Holding in Top 10
1
Calls
$41.2M
Puts
$42.9M
Top Buyers
| 1 | +$8.16M | |
| 2 | +$3.42M | |
| 3 | +$2.41M | |
| 4 |
Morgan Stanley
New York
|
+$1.93M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.26M |
Top Sellers
| 1 | -$4.27M | |
| 2 | -$3.15M | |
| 3 | -$1.23M | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$260K |
| 5 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
-$217K |